Grant of Options – 23 December 2009
23 December 2009 – The Board of Craneware plc (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, announces that on 22 December 2009, the Remuneration Committee approved the granting of share options to certain Directors to subscribe for ordinary shares of 1p each in the Company as follows:
|Director||No. of options granted||Percentage of issued share capital|
|Keith Neilson (Chief Executive Officer)||42,870||0.17|
|Craig Preston(Chief Financial Officer)||37,649||0.15|
The above options have been granted at an exercise price of 335p per share. These options will be subject to performance criteria, such that they vest in three equal tranches over three years. One third of the share options will vest on or after 30 June 2010, one third on or after 30 June 2011 and the final third on or after 30 June 2012. The share options will not become exercisable until three years from the date of the grant.
For further information, please contact:
- +44 (0) 131 550 3100
- Keith Neilson, CEO
- Craig Preston, CFO
- +44 (0 )20 7418 8900
- Oliver Scott
- Nicholas Marren
- +44 (0) 20 7653 9850
- Caroline Evans-Jones
- Fiona Conroy
Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance and mitigate risk for healthcare organisations. Craneware’s market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge and code for services and supplies associated with patient care. These optimise reimbursement, increase operational efficiency and minimise compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.
You might also like...
Jul 10, 2018 | Announcements
10 July 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, provides an update on trading for the year ended 30 June 2018. The Group is pleased to announce continued outstanding...read more
Apr 17, 2018 | Announcements
Schedule 6, Block Admission Period to 15 April 2018 This block admission announcement, as required by the AIM Rules, is made every six months and relates to the number of shares that have been issued and allotted during this six month...read more